HARBIN GLORIA PHARMACEUTICALS Co., LTD Stock Price

HARBIN GLORIA PHARMACEUTICALS Co., LTD, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamin supplements, electrolyte drugs, hypoglycemic drugs, analgesics, digestive system and metabolic drugs, anti-infective drugs, and anti-tumor drugs. It also provides deer antler polypeptide injections, Annao pills and tablets, potassium chloride sustained-release tablets, sodium creatine phosphate for injection, ginkgo biloba extract injections, vitamins (B12), fluorouracil for injection, bleomycin hydrochloride for injection, and other injectable products, as well as pravastatin sodium tablets, olmesartan medoxomil amlodipine tablets, and edoxaban tosylate tablets. In addition, the company engages in pharmaceutical promotion; project investment; investment services; trade import and export; wholesale and retail; and technology promotion and application services. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is headquartered in Harbin, the People’s Republic of China.